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Summary
Ionic liquids (ILs) are considered as another ’green solvent’, after the supercritical car-
bon dioxide. They are a promising reaction medium for biocatalysis process. The tolerance
of active cells in hydrophobic imidazolium-based ILs (1-R-3-methylimidazolium hexafluo-
rophosphate, [RMim][PF6]) has been studied in this work. Calcium-alginate-entrapped ba-
ker’s yeast has been chosen as the model of living cells. The results show that this kind of
ILs possess a certain degree of biocompatibility. The tolerance of yeast cells to the ILs de-
creases with the increase of the R chain length of these ILs. The experiment indicated that
1-butyl-3-methylimidazolium hexafluorophosphate ([BMim][PF6]) possessed excellent bio-
compatibility compared to the other imidazolium-based ILs. The moisture content in the
ILs was the key factor that affected the tolerance. The activity retention of yeast cells pre-
treated with [BMim][PF6] saturated with water and aqueous [BMim][PF6] biphasic system
was about 70 %, but it was only 50 % with the anhydrous [BMim][PF6]. Although the yeast
cells were pretreated with [BMim][PF6] for 24 h, the activity retention was up to 45 %. The
yeast cells had around 50 % activity after being pretreated 4 times with [BMim][PF6]. This
shows that the water immiscible ILs possess good biocompatibility, and they are suitable
for application as the reaction medium catalyzed by living cells.
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Introduction
Whole cell biocatalysis can be effectively used for
the production of enantiopure compounds (1,2). It is ap-
plied especially in asymmetric reduction of prochiral ke-
tones to produce the corresponding chiral alcohols as the
key chiral building blocks for many enantiopure pharma-
ceuticals (3). Many asymmetric reduction reactions with
excellent enantioselectivity are catalyzed by various mi-
crobes (3–7). However, the space-time yield does not
meet the practicable demand (8). Toxicity of the sub-
strate and product to living cells, and poor solubility of
substrates are the main obstacles (9,10). Coupling the
asymmetric reduction reaction with separation process
is a promising technique to improve the reaction effi-
ciency. The main idea is to introduce another phase as
the substrate reservoir and in situ extracting agent for
the reaction product (11,12). Macroporous adsorbing res-
ins and organic solvents have been successfully applied
as the second phase (13,14). Ionic liquids (ILs) should
also be applied as the second phase (15). In previous re-
ports the efficiency has not met the expectations (16),
the main reason is perhaps the biocompatibility of ionic
liquids with the living cell.
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Ionic liquids (ILs) are considered as another ’green
solvent’, after the supercritical carbon dioxide, due to their
excellent properties, such as nonvolatile, thermal stabil-
ity, designability, reusage and solvability to hydrophobic
substrate as well as being environmentally friendly (17).
That is why they have been recognized as an excellent
and promising biocatalysis medium, as an alternative to
conventional volatile chemical solvents (18). They were
successfully applied as the reaction media for the reac-
tions catalyzed by lipase and other enzymes (19). The
biocompatibility of ILs with enzymes and proteins has
been widely studied (20). Previous reports show that
ILs, especially the imidazolium-based and pyridinium-
-based ones, possess good biocompatibility with enzymes
and proteins (20). Unfortunately, there are very few re-
ports about the biocompatibility of ILs with active cell,
only Matsumoto et al. (21) and Ranke et al. (22) reported
some simple experiments on it. Matsumoto et al. (21)
used ILs as an extractant in the lactic acid fermentation
process. The toxicity of ILs to lactic acid bacteria (LAB)
was simply investigated by measuring the decrease of
the ability of LAB affected by ILs to produce lactic acid.
Ranke et al. (22) reported the ecotoxicity of ILs (methyl-
and ethyl-imidazolium ionic liquids) using Vibrio fischeri
and WST-1 cell as the model system. To our knowledge,
the biocompatibility of ILs with living cell has not been
reported in detail. It is important to understand the asy-
mmetric reduction process catalyzed by living cells with
ILs applied as substrate reservoir and product extractant
in situ.
The biocompatibility of imidazolium-based ILs is
studied in detail in the present work. Baker’s yeast is
chosen as the model of living cells, because it is the best
model cell for these asymmetric reduction reactions (3).
Imidazolium-based ILs, 1-R-3-methylimidazolium hexa-
fluorophosphate ([RMim][PF6]), are chosen as the research
object, since they are water immiscible and considered
to be the most promising ILs as the active cell biocata-
lysis medium (15,16,19). Also, this kind of ILs are tai-
lored solvents, i.e. their properties can be tailored to fit




1-butyl-, 1-pentyl, 1-hexyl- and 1-octyl-3-methylimi-
dazolium hexafluorophosphate ([BMim][PF6], [PMim][PF6],
[HMim][PF6] and [OMim][PF6], respectively) were used
in the work. The methodology in the preparation of these
ILs includes a metathesis of a bromide salt of the orga-
nic cation, [RMim]Br, with a sodium salt containing the
desired anion, NaPF6 (23). The structure of the ILs is
shown in Scheme 1. All other chemicals were of analyti-
cal purity grade and commercially available.
The active dried baker’s yeast was obtained from
Meishan-Mauri Yeast Co., Ltd. (China) and it was acti-
vated to obtain the living cells as described in our previ-
ous work (13).
Immobilization of yeast cell
Yeast cell was immobilized by the entrapped cal-
cium alginate. The activated cell paste was resuspended
in 25 mL of 20 mmol/L of Tris-HCl buffer (pH=7). The
cell suspension was then mixed with 75 mL of 2 % (by
mass per volume) sodium alginate solution prepared
using the same buffer. The alginate/cell solution was ex-
truded through a 19-gauge syringe needle, dripped into
chilled 0.1 mol/L calcium chloride solution, and allowed
to gel for 30 min at 4 °C. The hardened beads (3.3 mm
average diameter) were then dried on a paper towel and
stored at 4 °C in sealed vials. The cell mass of the al-
ginate beads was typically 90 mg of dry cell mass per
gram of beads.
Determination of the tolerance of yeast cells
treated with ILs
The main experimental procedure was the follow-
ing: the calcium-alginate-entrapped yeast cells were pre-
treated with the ILs for a certain period under the defi-
nite conditions described in the following paragraphs.
Then, the activity of the yeast cells was measured in two
ways. First, relative activity retention of the yeast cells
was measured by glucose consumption velocity. Second,
the ratio of living to dead cells was measured with an
optical microscope and haemocytometer based on meth-
ylene blue dye staining. They will be described in detail
in the following paragraphs.
Pretreatment of yeast cells with ILs
The pretreatment of yeast cells with ILs was carried
out in 10-mL screw-capped vials placed in a thermo-
static orbital shaker running at 75 rpm and 30 °C. Typi-
cally, a mass of 1.0 g of alginate beads (embedding yeast
cells) and 5 mL of ILs were added into each vial. After
12 h, the alginate beads were taken out by filtration and
washed with Tris-HCl buffer at 4 °C, after which the cell
activity was determined. Each experiment was carried
out three times in parallel, and the average results with
the standard deviation were recorded.
Measuring the relative activity retention by glucose
consumption velocity
The method is based on the glucose consumption
velocity (24). The procedure of the determination of rela-
tive activity retention of yeast cell pretreated with ILs
was the following: after pretreatment with ILs, the al-
ginate beads were added into 5 mL of Tris-HCl buffer
containing 2.0 g/L of glucose. The amount of consumed










Scheme 1. Imidazolium-based hexafluorophosphate ILs
glucose was determined in the first 30 min. Glucose con-
centration was determined with DNS method (25). The
relative activity retention of yeast cells was expressed as
follows:
/1/
where ni is the amount of glucose consumed after 30 min
by the yeast cells pretreated with Ils, and nb is the amount
of glucose consumed after 30 min by the yeast cells pre-
treated in a buffer (blank).
Measuring the ratio of living cells
The living and dead cells were identified, and the
ratio of living cells was calculated. The activity of cells
pretreated with ILs can also be expressed as the ratio of
living cells. The method to identify the dead and living
cells is based on methylene blue dye staining, which re-
veals the presence of cells with ruptured walls (26). The
dye causes the dead cells to appear dark blue, while the
living cells remain colourless. For this method, 0.1 g of
alginate beads pretreated with ILs were dissolved in 2
mL of sodium citrate solution (20 mmol/L of Tris, 20
mmol/L of Na3PO4, and 100 mmol/L of citric acid,
pH=7.0) for 1 h. Next, 0.2 mL of the dissolved alginate/
cell solution were mixed with 0.8 mL of methylene blue
dye solution (containing in g per 100 mL of distilled wa-
ter: methylene blue 0.025, NaCl 0.9, KCl 0.042, CaCl2
0.048, NaHCO3 0.02, and glucose 1). After 10 min, the
suspended mixture was added into the haemocytometer.
The living and dead cells were then able to be distin-
guished with an optical microscope, and the ratio of liv-
ing cells to total cells was recorded.
Results and Discussion
Effect of R-chain length of the imidazolium-based
ILs on yeast cell activity
The tolerance of yeast cells to imidazolium-based ILs
with different R-chain length was investigated. The
n-alkyl chain length of these ILs varied from 4 to 8 car-
bon atoms, which were saturated with water. The activ-
ity of calcium-alginate-entrapped yeast cells preincubated
with ILs is shown in Fig. 1. The relative activity reten-
tion based on glucose consumption velocity and the ra-
tio of living cells are both given in Fig. 1.
The results clearly show that the water immiscible
imidazolium-based ILs are biocompatible with yeast cells.
The activity of yeast cells decreases with the increase of
R-chain. [BMim][PF6] possessed the best biocompatibi-
lity compared to the other ILs. The relative activity re-
tention of yeast cells pretreated with [BMim][PF6] for 12
h reached up to 70 %. The results are consistent with the
previously published work about Gram-positive Lactoba-
cillus kefir in biphasic aqueous-ionic liquid system (21).
Also, Ranke et al. (22) found the ecotoxicity increasing
with lengthening of the n-alkyl chain using Vibrio fischeri
and the mammalian cell lines as the assay system in
their biological study of imidazolium-based ILs. How-
ever, these results are contrary to the effect of the alkyl
chain length on the activity and stability of enzymes in
imidazolium-based ILs (20,27,28). It has been reported
that the enzyme stability increased along with the alkyl
chain length increase. The reason for the inactivation of
enzymes in ILs is mainly that the enzyme is dissolved
in the Ils, while the effect of ILs on living cells is more
complicated.
It can be seen in Fig. 1 that relative activity retention
based on glucose consumption velocity is consistent
with the ratio of living cells. This indicates that the de-
termination of the cell activity based on glucose con-
sumption velocity is efficient, which is why only the rel-
ative activity retention was given in the following figures.
It is evident that the use of [BMim][PF6] as the reaction
medium for active cell biocatalysis process is preferable,
because of the good biocompatibility and the low eco-
toxicity (22).
To further understand the effect of alkyl chain length
on the biocompatibility of the ILs with yeast cells, the
change of the activity of yeast cells pretreated with the
intermediates of these ILs, i.e. 1-alkyl-3-methylimidazo-
lium bromide, was also investigated. The results are
shown in Fig. 2.
Comparing Fig. 2 to Fig. 1, it is evident that the
change in the trend of yeast cell activity in relation to
the alkyl chain length is similar to that of the ILs. How-
ever, the relative activity retention of yeast cells pre-
treated with these intermediates is obviously smaller
than of those pretreated with the corresponding ILs, al-
though they are also ILs, but their biocompatibility is
observably different from the corresponding hexafluoro-
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Fig. 1. Biocompatibility of imidazolium-based ILs with different
R-chain length with yeast cells

























Fig. 2. Biocompatibility of the intermediates with yeast cells
phosphate ILs. There are two reasons for the difference.
The first reason is that bromide is toxic to active cells,
and the second is that the intermediates are water misci-
ble, which results in the yeast cell dehydrating to be in-
active. The second reason may be the main cause. The
previous report also shows that only hydrophobic or
water immiscible ILs can be applied as the reaction me-
dium for active cell biocatalysis process (29).
Comparison of the cell activity between
immobilized and free cells
Two kinds of cells, free and immobilized, with en-
trapped calcium alginate, were used to investigate the
effect of the type of cell on the activity retention of yeast
cell in imidazolium-based ILs. Fig. 3 shows the experi-
ment results.
It is evident that the relative activity retention of
yeast cell entrapped in calcium-alginate bead is remark-
ably higher than that of free cell. Alginate, which is a
kind of hydrogel, is quite hydrophilic and it protects the
cell quite well against hydrophobic IL molecules be-
cause they have problems passing the barrier. This indi-
cates that immobilized cell is preferable for the biocata-
lysis process in IL medium. The result is similar to that
in organic solvent in a previous report (24).
Effect of moisture content of IL on the activity
of yeast cells
In biocatalysis in nonaqueous media, moisture con-
tent is the key factor of the reaction process, since it in-
fluences the biocatalyst activity. Perhaps the moisture con-
tent also influences the activity of yeast cell in IL. The
effect was investigated using anhydrous IL, biphasic
aqueous-ionic liquid medium and water-saturated IL.
Results are shown in Fig. 4.
The results show that there is obvious effect of
moisture content on the relative activity retention of the
yeast cells. Relative activity retention of the yeast cells
pretreated with anhydrous IL is the smallest, just about
50 %. However, when pretreated with biphasic aqueous
IL and water-saturated IL, it can be around 70 %. This
indicates that a certain amount of water is necessary
when IL is applied as the reaction medium, catalyzed by
active cells.
Effect of pretreatment period on the activity
of yeast cell
The effect of pretreatment period on the tolerance of
yeast cell was investigated. The pretreatment time was
increased from 6 to 54 h in water-saturated ILs. Results
are shown in Fig. 5.
Relative activity retention decreases with the in-
crease of contact time of yeast cell to ILs. However, the
downtrend is gentle when the contact time is longer
than 20 h. Although the yeast cells were pretreated with
[BMim][PF6] for more than 30 h, relative activity reten-
tion was able to reach 37.5 %.
Effect of pretreatment cycles on the activity of yeast cell
The effect of pretreatment with ILs on the activity of
the yeast cells was investigated. Results are given in Fig. 6.
Experiments indicate that the immobilized yeast
cells can be repeatedly used in ILs. Although pretreated
four times with [BMim][PF6], the relative activity reten-
tion can remain around 45 %.
Conclusions
The tolerance of yeast cells to imidazolium-based
hexafluorophosphate ILs was investigated in this work.
Experiments showed that the water immiscible ILs pos-
sess a certain degree of biocompatibility with active
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Fig. 4. Effect of moisture content on the activity of yeast cell in
[BMim][PF6]
A: anhydrous [BMim][PF6], B: biphasic aqueous [BMim][PF6],
C: water-saturated [BMim][PF6]



































Fig. 5. Effect of pretreatment period on the activity of yeast cell
in ILs
cells. Relative activity retention of yeast cells decreases
along with the increase of the length of alkyl chain of
the ILs, and it is the largest in [BMim][PF6], up to 70 %.
Moisture content is one of the key factors that influence
the yeast cell activity retention in ILs. Preferable cell ac-
tivity can be kept in water-saturated IL. The results
show that the ILs possess good biocompatibility and can
be applied as the biocatalysis reaction medium.
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Fig. 6. Effect of pretreatment with ILs on the activity of yeast
cell
